BioSpace News Archive

Policy

Will US Pharma See Lawsuits over COVID Vaccine Side Effects?

While the German biotech that partnered with Pfizer on a COVID vaccine sees its first lawsuit, legal experts don’t expect similar cases in the U.S.

June 20, 2023
·
4 min read
·
Lisa Munger
Business

AstraZeneca Mulls China Unit Spin-Off Amid Rising Tensions

As geopolitical tensions rise in the region, AstraZeneca is looking at potentially spinning off its China unit into its own independent business.

June 20, 2023
·
2 min read
·
Tristan Manalac
FDA

Lupin Launches Generic Thiamine Hydrochloride Injection in US

Following the FDA’s approval in March, India-based Lupin is launching its generic thiamine hydrochloride injection USP in the U.S. for treating vitamin B1 deficiency.

June 20, 2023
·
2 min read
·
Tristan Manalac
Deals

Lilly Aims to Boost Immuno Business with $2.4B DICE Buy

Eli Lilly stands to gain access to DICE Therapeutics’ DELSCAPE platform, which enables the design of orally available molecules for autoimmune and inflammatory diseases.

June 20, 2023
·
2 min read
·
Tristan Manalac
Drug Development

FDA Lifts Partial Hold on Arcellx’s Multiple Myeloma Trial After Patient Death

The study participant who died was apparently ineligible for the treatment according to the trial protocol, Arcellx announced Monday. The company has since retrained the study’s clinical sites.

June 20, 2023
·
3 min read
·
Kate Goodwin
Business

Thermo Fisher Cuts 88 Jobs in San Diego in Fourth Round of Layoffs This Year

The latest round of layoffs comes just two months after Thermo Fisher announced plans to close three sites in San Diego, bringing the total to nearly 600 jobs cut in 2023.

June 20, 2023
·
1 min read
·
Rosemary Scott
Policy

Biopharma Execs Weigh Controversial Move: Opting Out of Medicare to Escape Drug Price Negotiations

Biopharma executives suggested that some companies might seek to bypass the U.S. government’s national health insurance program altogether, among other sweeping changes to drug development.

June 20, 2023
·
5 min read
·
Heather McKenzie
Policy

Tribunal Rejects Boehringer Ingelheim’s Liabilities Against Sanofi for Zantac

An International Chamber of Commerce arbitration tribunal has dismissed Boehringer’s attempt to seek indemnification from Sanofi for the ongoing Zantac lawsuits faced by the companies.

June 20, 2023
·
2 min read
·
Alejandra Manjarrez
Santhera Grants Exclusive North America License for Vamorolone to Catalyst Pharmaceuticals in Deal Valued at up to USD 231 Million Plus Royalties

Santhera Pharmaceuticals announces that it has signed an exclusive license and collaboration agreement for vamorolone in North America with Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on novel medicines for patients living with rare diseases.

June 20, 2023
·
10 min read
Drug Development

argenx Initiates Second Cohort of Phase 2 ARDA Study of Empasiprubart in Multifocal Motor Neuropathy

argenx SE announced its plan to advance to a second dose cohort with the Phase 2 ARDA study of empasiprubart in multifocal motor neuropathy.

June 20, 2023
·
6 min read